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ABSTRACT 
Introduction. There have been few studies that examine the effects of platelet-rich 
plasma (PRP) on intestinal anastomotic healing. The applied preparation methods and 
PRP concentrations used in the few studies that have been carried out varied markedly. 
Therefore, the positive effects of PRP on the anastomotic healing process remain unclear. 5 
The aim of this study is to examine the effects of different concentrations of PRP on 
intestinal anastomotic healing. 
Material and Methods. From SD rat blood, three different concentrations of plasma 
were prepared: high-concentrated PRP (H-PRP: platelet count 5×106/mm3), 
low-concentrated PRP (L-PRP: 2×106/mm3), and platelet-poor plasma (PPP). Male SD 10 
rats underwent proximal jejunal anastomosis and central venous catheterization. Rats 
were divided into four groups (N=12 for each group): control, PPP, L-PRP, and H-PRP 
groups. Two types of PRP and PPP (0.21 ml) were applied to each anastomosis line, with 
the exception of the control group. Total parenteral nutrition (TPN) solutions were 
administered (151 kcal/kg/day). Five days after surgery, anastomotic bursting pressure 15 
(ABP) in situ and hydroxyproline concentration (HYP) in anastomotic tissue were 
evaluated.  
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Results. The ABP values of control, PPP, L-PRP, and H-PRP groups were 171±20, 
174±23, 189±17, and 148±25 mmHg, respectively. The HYP values of each group were 
516±130, 495±123, 629±120, and 407±143 μg/g dry tissue. Compared with the other 
groups, the L-PRP group exhibited a significant increase in both ABP and HYP, while 
the H-PRP group exhibited a significant decrease in these two variables. As a result, 5 
L-PRP was considered to promote anastomotic wound healing, but H-PRP was 
considered to inhibit it. There was no significant difference between the PPP group and 
the control group. 
Conclusions. PRP concentration plays a crucial role in the efficacy of PRP. PRP might 
exert positive effects on intestinal anastomotic healing in a dose-dependent manner up to 10 
a certain level, but adverse effects occur when it is highly concentrated. The essential 
PRP action appears to be driven by the platelets themselves． 
 
Key Words: platelet-rich plasma, platelet-poor plasma, gastrointestinal anastomosis, 
wound healing, PRP concentration, bimodal effect, anastomotic bursting pressure, 15 
hydroxyproline, rat. 
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INTRODUCTION 
Despite major advances in surgical techniques and perioperative management, the rates 
of gastrointestinal anastomotic leakage have still not been reduced to a negligible level. 
Anastomotic leakage has large negative impacts not only on mortality but also on 
long-term survival [1][2][3]. Hence, innovative methods to avoid anastomotic leakage are 5 
deemed necessary and are much anticipated. 
There is a growing body of evidence to demonstrate that platelet concentrates such as 
platelet-rich plasma (PRP) enhance wound healing in a variety of clinical fields on the 
basis of the premise that higher growth factor content should promote better healing 
[4][5][6][7][8]. Platelets contain high quantities of key growth factors, such as 10 
platelet-derived growth factor (PDGF) and transforming growth factor-β1 (TGF-β1)， 
which regulate cell proliferation and matrix remodeling [9]. PRP is regarded as a storage 
vehicle of growth factors. PRP application to gastrointestinal anastomosis is one of the 
most useful methods to deliver concentrated amounts of growth factors throughout the 
surgical site, and expected to accelerate the wound healing process. There have been only 15 
two reports regarding the effect of PRP application on intestinal wound healing [10][11]. 
However, these two reports provided contrasting results. Yol et al. showed that PRP has a 
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positive effect on wound healing in colonic anastomosis [10]. On the other hand, Fresno 
et al. indicated that PRP application only increases granulation tissue and fibrosis without 
improving jejunal anastomotic breaking strength [11]. Similarly, the effect of PRP 
remains a controversial subject in other research fields [12][13]. Behind the controversy 
is the fact that PRP preparation methods vary between studies, which results in 5 
significantly different platelet concentrations. Different platelet concentrations inevitably 
lead to different concentrations of various growth factors. Consequently, the platelet 
concentrations might be a crucial factor in determining whether PRP achieves the desired 
effects on wound healing. In addition, there is the possibility that the optimal 
concentration of PRP depends on the type of wound to which it is applied and adverse 10 
effects can be exerted when too high a concentration is used. 
The aim of this study is to clarify the causal relationship between PRP concentration and 
its effect on intestinal anastomotic healing. 
 
MATERIAL AND MEHODS  15 
Animals 
Seventy-seven male Sprague-Dawley rats (Nippon Clea, Tokyo, Japan), weighing 192 g 
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(172-252 g), were used in the experiment. The animals were maintained at 21°C with a 
12 h light/dark cycle and allowed free access to water and standard chow for 3 days. The 
experimental protocol was carried out in a humane manner after receiving approval from 
the Institutional Animal Experiment Committee of the University of Tsukuba, and in 
accordance with the Regulations for Animal Experiments of our university and the 5 
Fundamental Guidelines for Proper Conduct in Animal Experiments and Related 
Activities in Academic Research Institutions under the Jurisdiction of the Ministry of 
Education, Culture, Sports, Science, and Technology. 
Preparation of Platelet-Rich Plasma 
Ten milliliters of homologous fresh blood treated with 1 ml of ACD-A, anticoagulant 10 
solution, was obtained in a sterile tube from the heart of each rat. Blood was centrifuged 
immediately at 400 ×g and 22°C for 10 minutes. Blood was separated into three layers, red 
blood cells at the bottom, acellular plasma in the supernatant, and a buffy coat layer in 
between. The upper layer was transferred with a sterile pipette to another 10 ml centrifuge 
tube without buffy coat and re-centrifuged at 800 ×g and 22°C for 10 minutes. About 0.5 15 
ml of PRP (platelet count about 5.50×108/mm3) was pipetted from the bottom of the tube 
and about 1.0 ml of platelet-poor plasma (PPP) was harvested as a supernatant (Fig. 1A). 
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The prepared PRP, PPP, and whole blood of the rats were subjected to platelet and white 
blood cell counting with a cell counter (MICROS abc LC-152, HORIBA, ltd., Kyoto, 
Japan), and PPP was added a little at a time to adjust PRP to different platelet 
concentrations: low-concentrated PRP (platelet count 2×106/mm3) and high-concentrated 
PRP (platelet count 5×106/mm3). To produce a viscous coagulum gel that can be applied to 5 
the anastomosis, 180 μl of PRP was mixed with the “activator”, a mixture of 180 units of 
bovine thrombin (Sigma-Aldrich, St. Louis, MO, USA) and 30 μl of 10% calcium chloride. 
Calcium chloride neutralizes the anticoagulant effect of citrate, and bovine thrombin 
initiates the clotting process. Likewise, PPP was activated by the above-mentioned process. 
Finally, each of activated PRP and PPP was prepared as a total amount of 0.21 ml. The 10 
mixture, which clots within a few seconds, should be used immediately to allow the release 
of growth factors. 
Determination of PDGF-BB and TGF-β1 concentrations 
The activated PRP and PPP aliquots were incubated for 30 min at 37°C in a 5% CO2 
incubator (Auto-Flow incubator, NuAire, Inc., Plymouth, MN, USA). Samples were 15 
centrifuged for 10 min at 15500 ×g, and the supernatants were harvested. All 
supernatants were immediately stored at −80°C until further analysis. After being thawed, 
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the samples were assayed for platelet-derived growth factor-BB (PDGF-BB) and 
transforming growth factor-β1 (TGF-β1) by enzyme-linked immunosorbent assay 
(ELISA) testing (R&D Systems, Minneapolis, MN, USA). The levels of PDGF BB and 
TGF-β1 are reported in picograms per milliliter. 
Operative procedure 5 
Prior to surgery, all rats were fasted overnight. They were anesthetized by 
intraperitoneal injection of pentobarbital sodium (Somnopentyl®, Kyoritsu Seiyaku, 
Tokyo, Japan) at a dose of 40 mg/kg of body weight. Under aseptic conditions, (1) 
jugular vein catheterization at a central venous position was carried out. The tip of the 
catheter was a silicone tube of 0.5 mm inner diameter and 1.0 mm outer diameter (Fuji 10 
Systems Co., Tokyo, Japan), and the other part of the catheter was a plastic tube of 0.5 
mm inner diameter and 1.0 mm outer diameter (Imamura Co., Chiba, Japan). The distal 
end of the catheter was tunneled subcutaneously and brought out in the cephalad portion 
of the interscapular area. The catheters were fixed to the skin using a harness attached to 
a swivel assembly. (2) A laparotomy was performed through an upper midline incision 15 
measuring 3 cm. The proximal jejunum was divided 2.0 cm distal from the duodenum, 
and single-layer, end-to-end anastomosis was performed with 7-0 Proline sutures 
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(Ethicon Inc., USA) in an inverted interrupted fashion. To ensure technical uniformity, all 
anastomoses were sutured by only one surgeon. After that, the animals were divided into 
four groups: the control group (n=12), in which neither PPP or PRP was applied to the 
anastomosis line; the PPP group (n=12), in which activated PPP was applied to the 
anastomosis line; the low-concentrated PRP (L-PRP) group (n=12), in which activated 5 
low-concentrated PRP was applied to the anastomosis line; and the high-concentrated 
PRP (H-PRP) group (n=12), in which activated high-concentrated PRP was applied to the 
anastomosis line. In the PPP group, the L-PRP group, and the H-PRP group, the activated 
PRP or PPP was applied as a film layer of around 8 mm width and 3 mm thickness 
immediately after mixing with bovine thrombin and 10% calcium chloride (Fig. 1B). The 10 
fascial layer of the abdominal wall was closed with a continuous suture using 2-0 Silk 
(Ethicon Inc., USA), and the abdominal skin was closed in the same way. Following 
these procedures, the rats were maintained in individual metabolic cages for 5 days. 
Nutrient solutions 
In all groups, nutrient solutions (Neoparen 2, Otsuka Pharmaceutical Co., Ltd., Tokyo, 15 
Japan) were administered via the central venous catheter. Following surgical procedures, 
rats were maintained in individual metabolic cages for 5 days. Identical solutions were 
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administered to the four groups. Continuous infusion using infusion pumps (SP-115, JMS 
Co., Ltd., Tokyo, Japan) was initiated immediately after surgery. The full-dose energy 
intake was 151 kcal/kg body weight per day, equal to an infusion rate of 9 ml/kg body 
weight per hour. This target value corresponds to about 21 kcal/kg body weight per day 
for humans [14], which is thought to be reasonable during the acute phase of surgical 5 
stress [15]. Twenty-four hours postoperatively, half of the target calories had been 
administered. The reason why the rats were fed with TPN instead of standard rat chow 
and water ad libitum was to provide equivalent amounts of fluid volume and energy 
intake, which allows for leveling of the nutritional backgrounds of all rats. 
Nutritional parameters 10 
Urinary output was monitored daily, and body weights were recorded. On postoperative 
day 5, the rats were deeply anesthetized by an intraperitoneal injection of pentobarbital 
sodium at a dose of 40 mg/kg of body weight, and the infusion of nutrients was stopped. 
Blood was drawn from the inferior vena cava to determine the serum levels of total 
protein, albumin, glucose, and blood urea nitrogen.  15 
Anastomotic bursting pressure  
After the animals were anesthetized, the abdomen was opened, and the anastomotic 
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bursting pressure (ABP) was measured in situ without interruption of the normal 
mesenteric blood supply or adhesions to the anastomosis. A 16-gauge silicone rubber 
catheter was inserted 1.5 cm from the oral side of the anastomosis to the distal side. Two 
ligations were made, 1.5 cm proximal and distal from the anastomosis with 3-0 silk 
sutures. Normal saline solution was continuously infused through the catheter via a 5 
syringe pump at a rate of 1.0 ml/min. Intraluminal pressure was monitored continuously 
via a transducer (BLPR®, World Precision Instruments Inc., Sarasota, FL, USA) and 
recorded on a chart recorder (Power Lab®, AD Instruments, Tokyo, Japan). The ABP was 
defined as the peak pressure attained just before rupture of the anastomosis. 
Collagen concentration 10 
Hydroxyproline is useful as an index of collagen concentration because it is an amino 
acid unique to collagenous proteins [16]. After bursting of the anastomosis, 1 cm of the 
anastomotic segment, that is, 0.5 cm proximal and distal from the anastomosis, was 
excised and dissected free of mesenteric fat, intestine, and adherent omentum. Adhesions 
to the surrounding tissue were not dense, and it was feasible to separate adhesions from 15 
the anastomotic site using the blunt technique. The specimens were opened at the 
mesenteric side, gently washed with saline solution, and cut into three pieces. A strip of 
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the specimen was used to determine the concentration of hydroxyproline as an index of 
collagen concentration. The concentration of hydroxyproline was measured as described 
by Reddy and Enwemeka [17]. The procedure is based on alkaline hydrolysis of the 
tissue homogenate and subsequent determination of the free hydroxyproline in 
hydrolysate. Chloramine-T was used to oxidize the free hydroxyproline for production of 5 
a pyrrole. The addition of Ehrlich reagent resulted in the formation of a chromophore that 
can be measured at 550 nm. Calculations were made to express the result as micrograms 
of hydroxyproline per gram of dry tissue (μg/g dry tissue). 
Histopathological Analysis 
A strip of the anastomosis was immediately fixed in 10% phosphate-buffered 10 
formaldehyde, and then embedded in paraffin. One sample was randomly selected from 
each of the four groups. Histopathological sections (4 μm) were stained with 
hematoxylin-eosin (HE) and Masson trichrome (MT). The degree of collagen deposition 
was descriptively assessed in a blinded manner by two pathologists.  
Statistics 15 
All data are presented as the mean value ± standard deviation (SD). Comparisons among 
the four groups were tested by non-repeated measures ANOVA. Multiple comparisons 
 13 
were examined by Bonferroni test, and differences were considered statistically 
significant at p < 0.05.  
 
RESULTS 
Number of platelets and quantification of growth factor levels for three different 5 
concentrations of platelets  
Blood samples obtained from SD male rats exhibited an original platelet count of 0.91 ± 
0.12 × 106/mm3 and an original white blood cell count of 6.45 ± 1.53 × 103/mm3. PPP 
(n=5), L-PRP (n=5), and H-PRP (n=5) exhibited average platelet concentrations of 0.03 ± 
0.01, 2.11 ± 0.18, and 5.07 ± 0.19 × 106/mm3, respectively. These platelet concentrations 10 
represented 0.03-, 2.33-, and 5.60-fold increases compared with the original platelet count. 
None of PPP, L-PRP, and H-PRP included white blood cells. 
For PDGF-BB, 3439 ± 2817, 18462 ± 4671, and 49365 ± 4299 pg/ml were respectively 
determined in PPP, L-PRP, and H-PRP (Fig. 2). For TGF-β1, 5824 ± 1647, 101008 ± 
24584, and 210453 ± 37188 pg/ml were respectively determined in PPP, L-PRP, and 15 
H-PRP (Fig. 3). Both PDGF-BB and TGF-β1 values of H-PRP and L-PRP were 
significantly higher than those of PPP (p<0.01). Both PDGF-BB and TGF-β1 values of 
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H-PRP were significantly higher than those of L-PRP (p<0.01).  
Numbers of platelets in three different concentrations of platelets for surgical 
procedure 
Blood samples obtained from SD male rats exhibited an original platelet count of 0.93 ± 
0.12 × 106/mm3 and an original white blood cell count of 6.69 ± 2.34 × 103/mm3. PPP 5 
(n=12), L-PRP (n=12), and H-PRP (n=12) exhibited average platelet concentrations of 
0.06 ± 0.02, 1.93 ± 0.13, and 5.15 ± 0.30 × 106/mm3, respectively. These platelet 
concentrations were equivalent to 0.06-, 2.08-, and 5.53-fold increases compared with the 
original platelet count. None of PPP, L-PRP, and H-PRP included white blood cells. 
Nutritional parameters 10 
The initial body weight and body weight change 5 days after operation were similar in the 
four groups (Table 1). Total infusion volume, total energy intake, and total urine volume 
did not differ between the four groups (Table 1). There were no significant differences 
between the four groups in serum levels of total protein, albumin, glucose, or blood urea 
nitrogen (Table 2). These results indicated that there was no crucial factor directly 15 
impacting on intestinal anastomotic healing other than the effects of PRP. 
Anastomotic bursting pressure (ABP) 
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There was no intraperitoneal abscess formation, and no anastomotic leakage was noted 
in any animal. All tested anastomoses burst exactly at the suture line. The ABP values of 
the control group, the PPP group, the L-PRP group, and the H-PRP group were 171 ± 20, 
174 ± 23, 189 ± 17, and 148 ± 25 mmHg, respectively. In the L-PRP group, the ABP 
values were significantly higher compared with those in the control group, the PPP group, 5 
and the H-PRP group (p<0.05). On the other hand, the ABP values of the H-PRP group 
were significantly lower than those of the other three groups (p<0.05) (Fig. 4). No 
significant difference was detected between the PPP group and the control group. 
Collagen concentration in jejunal anastomotic tissue 
As a surrogate marker of collagen, the hydroxyproline concentrations of the control 10 
group, the PPP group, the L-PRP group, and the H-PRP group were 515 ± 130, 495 ± 123, 
629 ± 120, and 407 ± 143 μg/g dry tissue, respectively. In the L-PRP group, the 
hydroxyproline concentrations were significantly higher than those in the control group, 
the PPP group, and the H-PRP group (p<0.05). The hydroxyproline concentrations of the 
H-PRP group were significantly lower than those of the other three groups (p<0.05) (Fig. 15 
5). There was no significant difference between the PPP group and the control group. 
Histopathological examination in jejunal anastomotic tissue (Fig. 6) 
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In the L-PRP group, collagen deposition mainly in the serosal layer was most 
pronounced, a clear sign of increased collagen production, compared with those of the 
control group, the PPP group, and the H-PRP group. In contrast, the H-PRP group 
exhibited the smallest collagen deposition among the four groups. There was little 
difference between the control group and the PPP group. 5 
 
DISCUSSION 
Gastrointestinal wound healing is characterized by three phases of healing, namely, the 
inflammation phase, the proliferation phase, and the maturation phase. At the early phase, 
platelets play a key role in the wound healing process. After the formation of fibrin clots 10 
that serve as a scaffolding for platelets, platelets act during the first 72 hours of the 
inflammation phase. The initial and brief release of growth factors from platelets 
mediates the entire process by controlling growth, differentiation, and cell metabolism 
[18]. After that, macrophages take over the work of platelets, and initiate both wound 
debridement and the production of growth factors that modulate fibroplasia and 15 
angiogenesis. Because the anastomotic mechanical strength reaches the lowest value 3 or 
4 days after gastrointestinal anastomosis, the anastomotic leakage most commonly occurs 
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during this period [19]. From the above-mentioned viewpoint, the purpose of PRP 
application to gastrointestinal anastomosis is to accelerate the activation of fibroblasts 
and collagen formation by multiple viable growth factors released from platelets, which 
enables an increase in anastomotic strength at the earliest stage possible during the 
inflammation phase. 5 
In this study, PRP was prepared after two-step centrifugation of blood obtained from 
rats without any commercial kits. The advantage of this method is that both PRP and 
platelet-poor plasma (PPP) are easily available at the time, and the desired PRP 
concentration is fully adjustable by the addition of PPP. The concentration of each 
growth factor released from PRP is predictable on the basis of PRP concentrations. There 10 
is a possibility that concentrations of growth factors in PRPs differ according to species, 
such as rat, goat, and human [20]. Therefore, we quantified the numbers of platelets and 
two representative growth factors (PDGF-BB, TGF-β1) in three different concentrations 
of platelets (PPP, L-PRP, H-PRP) obtained from rat, and verified the relationship 
between numbers of platelets and concentrations of growth factors (Fig 2 and Fig 3). In 15 
our method, PRP excludes buffy coat completely. The influence of buffy coat including 
leukocytes is still unclear [21]. Some authors recommend the elimination of leukocytes 
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[22], while several studies have shown that leukocytes in buffy coat play a part in the 
effects of PRP [23]. In our experiment, the buffy coat layer was eliminated because the 
aim of this study is to investigate effects of PRP simply depending on different platelet 
concentrations. By adding thrombin to PRP as an activator, PRP works via the 
degranulation of the α-granules, which leads to the release of the following 7 5 
fundamental growth factors: the three isomers of platelet-derived growth factor 
(PDGF-AA, PDGF-BB, and PDGF-AB), two forms of transforming growth factor-β 
(TGF-β1 and TGF-β2), vascular endothelial growth factor (VEGF), and epidermal 
growth factor [24]. After this initial burst of PRP-related growth factors, platelets 
synthesize and secrete additional growth factors for the remainder of their life-span 10 
[10][11]. The addition of calcium chloride promotes the physiological clotting process, 
which leads to sound attachment of platelets to the anastomotic site and a sustained 
higher level of delivery of viable growth factors. Besides, clots also act as a suitable 
scaffold, where fibroblasts and endothelial cells can receive stimuli from several growth 
factors and proliferate. These growth factors are biologically active polypeptides, and 15 
most of them have key roles in every step of wound healing. Some reports demonstrate 
that the local application of PDGF-BB and/or TGF-β1 as a single agent enhances wound 
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healing [9][25][26]. Moreover, it was reported that the local injection of VEGF into the 
muscularis propria accelerates colonic anastomotic healing and strengthens the 
anastomosis by increased angiogenesis [27]. The specific characteristic of PRP is that it 
acts as a combination of multiple growth factors, each of which exerts a unique influence 
on the complex cascade of the wound healing process, and therefore should generate a 5 
synergistic effect unlike single recombinant growth factors that focus on a single function. 
As just described, the biological rationale for PRP application to various wounds seems 
to be theoretically sound, but its effects on intestinal anastomotic wound healing remain 
controversial [10][11]. To address this issue, we focused on the assumption that PRP has 
a dose-specific effect on intestinal anastomoses, and thus PRP concentration affects the 10 
outcome. 
In our study, the ABP values of proximal jejunal anastomoses in the L-PRP group, of 
which the PRP concentration corresponds to about a 2-fold increase over the original 
platelet concentration, were significantly higher than those of the other three groups 
(increased by 11% compared with that of the control group). There was no significant 15 
difference in the ABP values between the PPP group and the control group. PPP contains 
serum proteins such as fibrin, fibronectin, and vitronectin, known to act as cell adhesion 
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molecules, but very few platelets [28]. These findings might provide an explanation for 
the underlying mechanism of PRP action in intestinal anastomotic healing. The essential 
PRP action appears to be driven by platelets themselves, but not some serum proteins. On 
the other hand, the ABP values of the H-PRP group, of which the PRP concentration 
corresponds to about a 5-fold increase over the original platelet concentration, were 5 
significantly lower than those of the other three groups (decreased by 13.5% compared 
with that of the control group). The ABP is a more reliable measure for evaluating early 
postoperative anastomotic mechanical strength, especially within a week of the operation 
[16][29]. Generally, the bursting pressure is considered to reflect the physiological strain 
in the intestine more accurately than the breaking strength [16]. In addition, the bursting 10 
pressure shows indirect collagen formation and reflects the balance between collagen 
deposition and lysis [30]. Therefore, the ABP might be regarded as not only an integrated 
measure of anastomotic wound healing but also the absolute outcome of gastrointestinal 
anastomoses. Considering the physiological aspects of the ABP, we could conclude that 
L-PRP application significantly promoted jejunal anastomotic healing, but H-PRP 15 
application definitely impaired the wound healing process. Needless to say, the data on 
collagen concentration at the anastomosis coincided with the ABP results and reinforced 
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them. Furthermore, self-explanatory histopathological findings supported the 
above-mentioned conclusion. In the L-PRP group, there was clear evidence of increased 
fibroblast density and collagen formation primarily in the serosal layer. In this 
experiment, the proximal jejunum was divided, and then single-layer, end-to-end 
anastomosis was performed in an inverted interrupted fashion. This is also known as 5 
serosa-to-serosa anastomosis. The essence of this anastomotic technique is full-thickness 
intestinal anastomosis with serosal apposition, which places importance on union of the 
wound, especially in the serosal layer. In fact, the application of L-PRP increased the 
anastomotic mechanical strength by accelerating collagen formation in the serosal layer, 
which should be central to wound healing. To the best of our knowledge, this paper is the 10 
first report demonstrating that PRP concentration plays a crucial role in the effect of PRP 
on intestinal anastomotic healing. Although PRP might exert positive effects in a 
dose-dependent manner up to a certain level, excessive PRP concentration results in 
serious adverse effects rather than no effect. Our results correlated with the findings of 
several previous studies [24][31]. By evaluating the effect of different concentrations of 15 
PRP on osteoblast and fibroblast functions in vitro, Graziani et al. reported that maximal 
PRP concentrations used in their study, which varied between 4.2- and 5.5-fold increases 
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over the original platelet concentration, might not provide the optimal environment for 
the promotion of wound healing. Optimal results were observed at a platelet 
concentration of 2.5-fold, which was approximately half of the maximum concentration 
that could be obtained [24]. It has remained unclear how PRP highly concentrated above 
a certain level interferes with the normal wound healing process. However, 5 
one-dimensional thinking of “if some is good, more is better” is not recommended for 
PRP application to intestinal anastomoses. To achieve the desired effect of PRP on 
intestinal wound healing, the use of PRP at the optimal density is thought to be 
imperative. The present results provide a possible explanation for the existing criticism of 
the efficacy of PRP. Future studies should be designed with the understanding that the 10 
PRP concentration plays a crucial role in the efficacy of PRP. 
Some limitations of our study need to be addressed. First, a potential weakness of our 
experiment is the use of homologous PRP, but not autologous PRP. Originally, the term 
PRP refers to an autologous concentration of platelets in a small volume of plasma. In 
small animal models such as rats, the blood volume is too small to produce autologous 15 
PRP. Inevitably, donor blood is commonly used. It has been pointed out that the use of 
donor animal blood platelets conveys a risk of imparting an overt immune reaction, 
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which could lead to false-negative results [31]. However, our study could remove such 
doubts because of the demonstration of positive effects of PRP in the L-PRP group. 
Second, we just investigated the overall biological properties of PRP but have yet to 
evaluate all sorts of growth factors included in PRP individually in this study. In the next 
stage, we need to identify the factor or factors that actually improve the anastomotic 5 
strength and healing. 
Finally, we propose the following vision for clinical practice. PRP can be easily 
prepared from only 20-40 cc of autologous blood of the patient. After obtaining 
autologous blood of the patient, the whole process takes no more than one hour. When 
centrifugal machines are present in the operating room, we can proceed with the 10 
preparation of PRP depending on the progress of the operation and accomplish the whole 
process inside the operating room. Needless to say, quality control mechanisms are 
always essential. First, PRP applied to the wound should be prepared at the optimal 
concentration that allows for maximum enhancement of wound healing. Second, “fresh 
PRP” needs to be used. “Fresh PRP” implies that each platelet is alive and active in PRP. 15 
Otherwise, PRP cannot fully exert its positive effect on wound healing because platelets 
are expected to synthesize and secrete additional growth factors for the remainder of their 
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lifespan after the initial burst of PRP-related growth factors. In concrete terms, we think 
that the clinical application of PRP can be targeted at patients who undergo 
gastrointestinal anastomoses under unfavorable conditions for wound healing. In such 
cases, leakage of intestinal anastomosis can occasionally occur, even though 
gastrointestinal anastomosis is performed correctly and complies with the tension-free 5 
construction of the suture, with adequate tissue perfusion. There should be a factor that 
delays or impairs wound healing, but it is difficult to determine the specific cause of 
anastomotic leak because the process of wound healing is very complex and depends on 
many factors. Not surprisingly, specific individual countermeasures cannot be taken 
because the specific cause cannot be identified. Therefore, we focus on PRP working as a 10 
storage vehicle of growth factors. PRP is expected to coordinate the process of wound 
healing and handle various dangerous situations prone to the occurrence of anastomotic 
leak. PRP might achieve the desired effect to accelerate wound healing and ensure 
adequate anastomotic mechanical strength earlier than normal, which would lead to the 
prevention of anastomotic leak under adverse conditions. In the case of patients with 15 
cancer, the risks of using PRP should be taken into full account. PRP application to an 
anastomotic site is essentially a local therapy, not a systemic therapy (e.g., blood 
 25 
transfusion). In addition, the actual number of platelets administered as the modality of 
PRP is extremely low compared with the total number of platelets given as the modality 
of platelet transfusion. Therefore, it is unlikely that PRP application to an anastomotic 
site stimulates remnant cancer cells in other remote regions. Generally, there seems to be 
little likelihood that PRP application worsens clinical outcome after cancer operation. 5 
However, there are some alarming pathological conditions. In particular, in the case of 
subclinical peritoneal metastasis, PRP application might pose a risk of local recurrence in 
the area surrounding the anastomotic site by stimulating cancer cells with a variety of 
growth factors derived from PRP. In such cases, PRP application might hasten cancer 
recurrence as well.  10 
CONCLUSION 
PRP might exert positive effects on intestinal anastomotic healing in a dose-dependent 
manner up to a certain level, but adverse effects occur at a high concentration. The 
essential PRP action might be driven by the platelets themselves, but not by some serum 
proteins. Further investigations are needed to clarify the optimal PRP concentration that 15 
allows for maximum enhancement of anastomotic wound healing. 
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Figure legends 
Fig 1. Actual preparation of PRP and application of PRP to the jejunal anastomotic site.  
A: The arrow indicates PRP and the arrowhead indicates platelet-poor plasma. B: The 
arrow indicates activated PRP covering the anastomotic site.  
 5 
Fig 2. The determination of PDGF-BB concentrations in three different concentrations of 
platelets.  
PPP: platelet-poor plasma, L-PRP: low-concentrated platelet-rich plasma, H-PRP: high- 
concentrated platelet-rich plasma. Each column represents the mean value ± standard 
deviation of PDGF-BB in each concentration of platelets; *: p<0.01 versus the PPP, †: 10 
p<0.01 versus the L-PRP (non-repeated measures ANOVA and Bonferroni’s multiple 
t-test). 
 
 33 
Fig 3. The determination of TGF-β1 concentrations in three different concentrations of 
platelets.  
PPP: platelet-poor plasma, L-PRP: low-concentrated platelet-rich plasma, H-PRP: high- 
concentrated platelet-rich plasma. Each column represents the mean value ± standard 
deviation in each concentration of platelets; *: p<0.01 versus the PPP, †: p<0.01 versus 5 
the L-PRP (non-repeated measures ANOVA and Bonferroni’s multiple t-test). 
 
Fig 4. Anastomotic bursting pressure 5 days postoperatively in the four groups.  
Control: without application of PPP or PRP to the anastomosis line; PPP: with 
application of PPP to the anastomosis line; L-PRP: with application of low-concentrated 10 
PRP to the anastomosis line; H-PRP: with application of high-concentrated PRP to the 
anastomosis line. Each column represents the mean value ± standard deviation of rats in 
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the four groups; *: p< 0.05 versus the control, PPP, and H-PRP groups, †: p<0.05 versus 
the control, PPP, and L-PRP groups (non-repeated measures ANOVA and Bonferroni’s 
multiple t-test). 
 
Fig 5. The concentration of hydroxyproline in jejunal anastomosic tissue 5 days 5 
postoperatively in the four groups.  
Control: without application of PPP or PRP to the anastomosis line; PPP: with 
application of PPP to the anastomosis line; L-PRP: with application of low-concentrated 
PRP to the anastomosis line; H-PRP: with application of high-concentrated PRP to the 
anastomosis line. Each column represents the mean value ± standard deviation of rats in 10 
the four groups; *: p< 0.05 versus the control, PPP, and H-PRP groups, †: p<0.05 versus 
the control, PPP, and L-PRP groups (non-repeated measures ANOVA and Bonferroni’s 
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multiple t-test). 
 
Fig 6. Typical histopathological appearance of the jejunal anastomosis 5 days 
postoperatively in the four groups.  
A1-A3: Control without application of PPP or PRP to the anastomosis line; B1-B3: PPP 5 
with application of PPP to the anastomosis line; C1-C3: L-PRP with application of 
low-concentrated PRP to the anastomosis line; D1-D3: H-PRP with application of high- 
concentrated PRP to the anastomosis line. A1-D1: 40-fold magnified hematoxylin and 
eosin stain (HE 40×); A2-D2: 40-fold magnified Masson trichrome stain (MT 40×); 
A3-D3 100-fold magnified Masson trichrome stain (MT 100×).  10 
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Table 1. Nutritional parameters in the four groups. 
 Control  PPP  L-PRP  H-PRP   
Initial body weight (g) 195  ± 21   209  ± 19   199  ± 16   207  ± 15   N.S 
Body weight change (%) 1.7  ± 2.3   3.0  ± 1.3   2.0  ± 2.1   2.8  ± 3.4   N.S 
Infusion volume (ml/5 days) 190  ± 23   196  ± 21   191  ± 14   197  ± 14   N.S 
Energy intake (kcal/5 days) 155  ± 19   161  ± 17   157  ± 11   162  ± 12   N.S 
Urine volume (ml/g/5 days) 0.53  ± 0.06   0.54  ± 0.05   0.59  ± 0.05   0.50  ± 0.07   N.S 
Control: without application of PPP or PRP to the anastomosis line; PPP: with application of PPP to the anastomosis line; L-PRP: with 
application of low-concentrated PRP to the anastomosis line; H-PRP: with application of high-concentrated PRP to the anastomosis line. All 
values represent the mean value ± standard deviation of rats in each of the four groups. Total infusion volume, total energy intake, and total urine 
volume did not differ between the four groups (non-repeated measures ANOVA). N.S.: no significance. 5 
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Table 2. Biochemical nutritional parameters in the four groups. 
 Control  PPP  L-PRP  H-PRP   
Total protein (g/dl) 4.6  ± 0.5   4.5  ± 0.3   4.7  ± 0.3   4.8  ± 0.3   N.S 
Serum albumin (g/dl) 2.5  ± 0.5   2.6  ± 0.3   2.5  ± 0.3   2.6  ± 0.3   N.S 
Glucose (mg/dl) 183  ± 102   229  ± 221   175  ± 68   153  ± 41   N.S 
Blood urea nitrogen (mg/dl) 12.0  ± 2.6   10.5  ± 5.3   13.3  ± 4.8   12.4  ± 2.7   N.S 
Control: without application of PPP or PRP to the anastomosis line; PPP: with application of PPP to the anastomosis line; L-PRP: with 
application of low-concentrated PRP to the anastomosis line; H-PRP: with application of high-concentrated PRP to the anastomosis line. All 
values represent the mean value ± standard deviation of rats in each of the four groups. There were no significant differences in serum levels of 
total protein, albumin, glucose, and blood urea nitrogen between the four groups (non-repeated measures ANOVA). N.S.: no significance. 5 
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Fig.3 The determination of TGF-β1. 
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Fig.4 Anastomotic bursting pressure in the four groups 
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Fig.5 Concentration of hydroxyproline in jejunal anastomotic tissue in the four groups 
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Fig.6 Histological finding of anastomosis 
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